Saving Ends In...
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Day 0 – Sept 22, 2026 - ET (Eastern Time, GMT-05:00)
The Biotech CEO Forum is an exclusive gathering designed for CEOs of private-stage biotech companies, ranging from start-ups to growth-stage enterprises. This forum provides a confidential and collaborative environment for biotech leaders to share their experiences, challenges, and strategies. Discussions will focus on overcoming business growth obstacles, navigating capital markets, forming strategic partnerships, and scaling innovations to market. Attendees will leave with actionable insights and tangible takeaways to drive their companies forward, while building meaningful connections with peers and industry leaders.
As China solidifies its position as a global biopharma innovation powerhouse, understanding how to structure and execute successful partnerships has become mission-critical for pharma and biotech companies worldwide. This masterclass provides senior executives and business development professionals with a comprehensive framework for navigating the complexities of China partnerships in 2026.
East Meets West: Structuring Win-Win China Partnerships
As cross-border collaborations between Western pharma/biotech and Chinese innovators accelerate, the ability to structure mutually beneficial deals has become a competitive differentiator. This panel brings together pharma business development leaders and investors with deep China experience to share practical insights on what makes partnerships succeed—and where deals commonly falter. Panelists will discuss real-world approaches to balancing opportunity with risk, navigating cultural and regulatory differences, and building trust across borders in an increasingly complex geopolitical environment.
- Deal Structure & Valuation: How are valuation approaches and deal terms evolving for China-originated assets, and how do you price in regulatory and geopolitical risk?
- Due Diligence & Trust-Building: What are the non-negotiables in vetting Chinese partners, and what strategies help bridge cultural differences and build lasting trust?
- Regulatory Pathways & Market Access: How are FDA/EMA policies on China data impacting partnership strategies, and what's working for dual-market commercialization planning?
The Pharma Partnering Forum is a focused session designed to help biotech companies understand the intricacies of partnering with pharmaceutical companies. This forum provides biotech leaders with insights into the latest trends in pharma-biotech collaborations, licensing agreements, and M&A strategies. Attendees will learn about best practices for approaching pharma partners, structuring deals, and navigating the complexities of partnership negotiations. The session is tailored to equip biotech executives with the knowledge and strategies needed to successfully engage with pharma companies and drive their business growth.
The Financing Masterclass is a focused session tailored for private-stage biotech companies seeking to secure funding and optimize their financial strategies. This masterclass will cover critical topics such as venture capital trends, corporate venture capital strategies, IPO preparation, and alternative financing options. Led by industry experts, the session will provide biotech leaders with the tools and knowledge to effectively pitch to investors, structure financing rounds, and position their companies for long-term growth. It is an essential resource for biotech executives navigating the evolving investment landscape.